Influenza vaccine: Flucelvax Quadrivalent approved for people two years of age and older
by Press Release from Outbreak News Today on (#5F0P3)
By NewsDesk @bactiman63 Seqirus announced this week that the U.S. Food and Drug Administration (FDA) has approved FLUCELVAX(R) QUADRIVALENT (Influenza Vaccine), the company's cell-based quadrivalent influenza vaccine (QIVc), for an expanded age indication for people two years of age and older. FLUCELVAX QUADRIVALENT was previously FDA-approved for use in persons four years of age and older. FLUCELVAX [...]
The post Influenza vaccine: Flucelvax Quadrivalent approved for people two years of age and older appeared first on Outbreak News Today.